Session 2R

Genes and Proteins in Human Disease

3:30 PM to 5:00 PM | Moderated by Joachim Voss


A Rare Genomic Duplication Creates a Novel Transcript in DNA Of a Patient with Schizophrenia
Presenter
  • Molly J Gasperini, Senior, English, Biology (Molecular, Cellular & Developmental) Mary Gates Scholar
Mentors
  • Mary-Claire King,
  • Caitlin Rippey,
Session
  • 3:30 PM to 5:00 PM

A Rare Genomic Duplication Creates a Novel Transcript in DNA Of a Patient with Schizophreniaclose

Rare, gene-disrupting genomic deletions and duplications – called copy number variants (CNVs) – have been implicated in schizophrenia; however, much remains to be understood about which genes are causative, as well as the genetic and cellular mechanisms involved. We used array Comparative Genomic Hybridization to screen DNA from individuals with schizophrenia for such CNVs. From the rare mutations detected, we focused on one that duplicates the 5' ends of two genes that lie head-to-head on chromosome 11q22. Both DCUN1D5, a ubiquitin ligase, and DYNC2H1, a dynein active in cilia, are expressed in brain and are plausible candidate genes for schizophrenia. In order to detect and characterize aberrant transcripts resulting from this duplication, we performed next generation sequencing (RNAseq) of total mRNA from lymphoblasts of the patient. We found multiple different transcripts unique to this patient, indicating novel expression and splicing of the genomic sequence now adjacent to the 5' end of DCUN1D5. PCR and Sanger sequencing confirmed that these novel exons constitute a new 3' end of the mutant, truncated DCUN1D5. Next we will quantify relative levels of these novel transcripts by cloning and attempt to detect the predicted truncated protein by Western blotting. These data support the role of this mutation in schizophrenia by confirming the presence of aberrant transcripts in the patient's RNA. The data also suggest an intriguing mechanism by which a genomic rearrangement can result in a novel, stable transcript via “exonification” of otherwise non-coding sequence.


The Role of Wnt3a in Melanoma Cell Apoptosis
Presenter
  • Jamie Michelle (Jamie) Goodson, Senior, Biology (Molecular, Cellular & Developmental) Mary Gates Scholar
Mentors
  • Randall Moon,
  • Travis Biechele,
Session
  • 3:30 PM to 5:00 PM

The Role of Wnt3a in Melanoma Cell Apoptosisclose

Melanoma is a human skin cancer which is notoriously difficult to treat. Many melanomas are characterized by a mutant B-raf gene which causes constitutive activation of the B-raf protein. A drug called Plx has been developed to inhibit this mutant B-raf, and though it shows promise, many patients show relapse. The Moon lab has found that when melanoma cells are treated with Wnt3a and GDC, a PI3 kinase inhibitor, alongside Plx, the rate of apoptosis is drastically increased. To test this I have treated cells with Plx and GDC in the presence and absence of Wnt3a. I then assayed for apoptosis using flow cytometry on cells stained for apoptosis markers, and TUNEL staining as another test for apoptosis. My results confirm that in combination, Wnt3a, Plx and GDC enhance apoptosis compared to treatment of each alone. These results could have important implications for enhancing the efficacy of Plx treatment in patients.


Transcriptional Roles of Individual Control Elements within the Regulatory Regions of a Muscle Gene
Presenter
  • Bi Ying Huang, Senior, Biochemistry
Mentor
  • Steve Hauschka,
Session
  • 3:30 PM to 5:00 PM

Transcriptional Roles of Individual Control Elements within the Regulatory Regions of a Muscle Geneclose

Muscle Creatine Kinase (MCK) is among the most transcriptionally active genes in skeletal and cardiac muscles. The Hauschka lab has isolated a 6.5kb region of MCK that contains all of the known regulatory regions necessary for high-level muscle-specific activity. A 1kb sub-region (MR1) located in MCK’s first intron is responsible for ~50% of the total muscle-specific activity. Further analysis demonstrated that most of MR1’s activity was specified by a 95bp small intronic enhancer (SIE). Tests of the SIE inserted upstream of the MCK proximal promoter showed that its activity is due to three control elements, a left Ebox, a right Ebox and a MEF2 site. However, these studies used gene constructs from which ~6kb of the MCK gene’s total regulatory regions had been removed. My research focuses on the transcriptional activity of individual control elements in the context of the entire 6.5kb MCK regulator region, as this is more representative of the gene’s natural structure. I have repeated the original experiments and have also generated site-directed mutations of the Eboxes and MEF2 sites with oligonucleotide PCR primers. After verifying these mutations by sequencing, the test constructs will be ligated into plasmids upstream of the Luciferase reporter gene. The effects of changing the control elements will be tested by transfections of skeletal and cardiac muscle cells and comparing the activity of mutated constructs to the wild type 6.5kb MCK construct. Results from these experiments should indicate the relative contribution to transcriptional activity of the three control elements. The experiments will be the first to determine whether individual control elements contribute to the total activity of the MCK gene’s entire 6.5kb regulatory region. Alternatively if the mutations have no effects they can be used in assays to detect MCK gene regions that compensate for the mutations.


Investigation of Homologous Recombination Efficiency in Agrobacterium tumefaciens C58
Presenter
  • James McDonald, Senior, Biochemistry, Seattle Pacific University
Mentors
  • Derek Wood, , Seattle Pacific University
  • Katey Houmiel, , Seattle Pacific University
Session
  • 3:30 PM to 5:00 PM

Investigation of Homologous Recombination Efficiency in Agrobacterium tumefaciens C58close

In bacteria, homologous recombination (HR) is a DNA repair mechanism that facilitates genetic manipulations. The product of the recA gene is a critical part of the HR mechanism. In Agrobacterium tumefaciens C58 (C58), efficient HR relies on at least 1.2 kilobases (kb) of homologous DNA. This relative inefficiency makes engineering strains for functional analysis challenging. Namsarev et al. have shown that the replacement of Escherichia coli recA with Pseudomonas aeruginosa recA produces an 8-fold increase in the frequency of recombination events (FRE). In light of this, we investigated the effect of replacing the C58 recA gene with the recA gene from Azotobacter vinelandii DJ (DJ). DJ recA, which is about 90% similar to P. aeruginosa recA, promotes efficient recombination with less than 300 base pairs (bp) of homologous DNA. This suggests that the replacement may enhance recombination in C58. A recA replacement vector, created using splicing by overlap extension (SOE) PCR, was transferred into a rifampicin-resistant strain of C58 where HR was used to replace the wild type recA. This mutant strain, AtuC58recAAv, was then used to assess recombination by recovery of single and double crossover events on selective media. The vectors used in these experiments contained 1.5, 1.0, and 0.5 kb of homologous DNA. When this analysis was performed on both single and double recombinant strains, recombination efficiency increased when both recA genes were present. The greatest recombination efficiency occurs with 1.0 kb of homology. Surprisingly, neither the strain containing DJ recA nor the 1.5 kb test vector produced the highest recombination efficiency.


Bone Marrow Stromal Cell Effect on Cardiomyocyte Survival in a Rat Infarct Model
Presenter
  • Amy Torkelson, Senior, Biology (General)
Mentor
  • Christopher Burtner,
Session
  • 3:30 PM to 5:00 PM

Bone Marrow Stromal Cell Effect on Cardiomyocyte Survival in a Rat Infarct Modelclose

          Cardiomyocytes are cells found specifically in heart tissue that do not proliferate in adults.  This is major issue when injury such as myocardial infarction occurs to the heart and fibrotic scar tissue populates the area of injury.  Cellular tissue grafts are a therapy used to regenerate the myocardium and improve heart function after such events.  However, survival of the graft to improve heart function is rare due to the fibrotic scare tissue around the infarct.  A focus of researchers is to develop methods to increase survival of the graft.  Our lab has observed that co-injecting bone marrow stromal cells (BMSC) with neonatal cardiomyocytes leads to increased survival of the cardiomyocyte population.  Although, the BMSCs have poor survival under these conditions.  BMSCs are pluripotent adult stem cells which reside in the bone marrow, and are distict from hematopoietic stem cells.  They have also been shown to avoid allorecognition and generate a local immunosuppressive microenvironment, meaning they will not be rejected by an individual’s immune system when coming from a donor.  We hypothesize that the bone marrow stroma is composed of a mixture of cell types.  To test our hypothesis we have isolated 39 BMSC clones for gene expression and functional analysis.  Preliminary results show differences between the clones and more assays are currently being developed to look further into the differences.  The overall goal is to improve cardiomyocyte survival in vivo in the rat infarct model. 


Regulation of the Helicobacter pylori SabA Adhesin by Phase Variation
Presenter
  • Shawn Emily Whitefield, Senior, Biology (General), Individualized Studies Mary Gates Scholar
Mentors
  • Nina Salama, , Fred Hutchinson Cancer Research Center
  • Sarah Talarico, , Fred Hutchinson Cancer Research Center
Session
  • 3:30 PM to 5:00 PM

Regulation of the Helicobacter pylori SabA Adhesin by Phase Variationclose

Over half the global population is infected with Helicobacter pylori and a subset of infected individuals develop severe clinical disease (peptic ulceration and gastric cancer). H. pylori can vary pathogenicity through reversible genetic changes in protein expression by phase variation. The sabA gene encodes an adhesin that mediates extracellular binding of H. pylori to host tissue. Expression of sabA can be regulated by translational phase variation resulting from slipped-strand mispairing during DNA replication of dinucleotide repeats of cytosine and thymine (CT) at the 5’ end of the protein coding sequence. However, we have observed discrepancies between predicted SabA protein expression based on the sabA CT repeat gene sequence and detection of SabA protein expression by Western blot. This lead us to hypothesize that there may be additional transcriptional phase variation through a variable poly-thymine (poly-T) tract in the promoter that also affects the level of SabA protein expression. To test this hypothesis, I have engineered an H. pylori strain (SW1) with an antibiotic resistance marker under control of the sabA promoter. By subjecting this strain to a reporter gene assay, I can examine the relationship between sabA promoter activity and poly-T tract length. I have sequenced the sabA promoter of 24 SW1 clones. Among 15 clones displaying high sabA promoter activity, 19 T’s (10), 18T’s (4) and 17T’s (1) were observed. I will also analyze the promoter sequence of strains with low promoter activity. In a separate experiment, I will perform Western blotting to assess SabA expression of 52 H. pylori clinical strains and correlate expression levels with both CT tract and poly-T tract length. Understanding H. pylori regulation of host-pathogen interactions via altering SabA adhesin expression could aid in reducing adverse public health effects including the 5.5% of all cancer cases worldwide caused by H. pylori.


The University of Washington is committed to providing access and accommodation in its services, programs, and activities. To make a request connected to a disability or health condition contact the Office of Undergraduate Research at undergradresearch@uw.edu or the Disability Services Office at least ten days in advance.